NDC 0074-1824 - Novocain
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0074-1824
- Package NDCs from labels
- 0074-1824-30
- Manufacturer
- Hospira, Inc.
- Effective date
- 2007-04-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP | Hospira, Inc. | 2007-04-16 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0074-1824-30 | Novocain | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 1 | |
| 0074-1824-30 | Novocain | 100 in 1 CASE | INJECTION, SOLUTION | 100 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Procaine Hydrochloride | ACTIVE INGREDIENT | 95URV01IDQ | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Procaine | ACTIVE MOIETY | 4Z8Y51M438 | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Acetone Sodium Bisulfite | INACTIVE INGREDIENT | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | ||
| Chlorobutanol | INACTIVE INGREDIENT | HM4YQM8WRC | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Chloride | SODIUM CHLORIDE | Walgreen Company | d112a344-33cc-41d3-bae6-492631ebdba7 | 2025-11-19 | Warnings | Sodium Chloride |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | ce0c8c6f-734a-400f-9b60-a3b1e263f25f | 2025-11-18 | Warnings, Adverse reactions | Sodium chloride |
| Sodium Chloride | SODIUM CHLORIDE TABLETS | Kesin Pharma Corporation | 2f107592-10c5-ef3b-e063-6394a90a7c0a | 2025-11-17 | Warnings | Sodium Chloride |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Hospira, Inc. | af6aebad-ef03-4d19-9a40-18e5a278b812 | 2025-11-11 | Warnings, Adverse reactions | SODIUM CHLORIDE Hospira, Inc. |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Henry Schein, Inc. | 2e81ffca-05c6-4fa0-8911-4b3cbfa71351 | 2025-11-07 | Warnings, Adverse reactions | SODIUM CHLORIDE |
| Sodium Chloride | SODIUM CHLORIDE | Rising Pharma Holdings, Inc. | 42870188-b1d7-4934-a6c0-310530497dac | 2025-11-07 | Warnings | Sodium Chloride |
| Sodium Chloride | SODIUM CHLORIDE | Henry Schein, Inc. | d8b8d796-bfba-42af-a859-99d776871558 | 2025-11-07 | Adverse reactions | Sodium Chloride |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | ea20a5eb-641e-48cd-bcfa-74c04c45dfda | 2025-11-06 | Warnings, Adverse reactions | Hospira, Inc. |
| Ciprofloxacin in Dextrose | CIPROFLOXACIN | Hospira, Inc. | cbbbf939-3219-4515-a48e-ca264daa4d07 | 2025-11-04 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Irinotecan Hydrochloride | IRINOTECAN HYDROCHLORIDE | Hospira, Inc. | 5c527c2e-9062-4afe-dbbb-f650db3a340f | 2025-11-03 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | ICU Medical Inc. | 3cfdeee0-ff14-4341-8396-b11c2a037c60 | 2025-11-02 | Warnings, Adverse reactions | Sodium Chloride |
| Sodium Chloride | SODIUM CHLORIDE | ICU Medical Inc. | 5f372b75-d7a4-471e-8ac6-290040fc84b0 | 2025-11-02 | Warnings, Adverse reactions | Sodium Chloride |
| Sodium Chloride | SODIUM CHLORIDE | ICU Medical Inc. | 009bef3c-e8ac-46be-b564-a2556adf0081 | 2025-10-31 | Warnings, Adverse reactions | Sodium Chloride |
| Erythrocin Lactobionate | ERYTHROMYCIN LACTOBIONATE | Hospira, Inc. | a96c405f-bd70-4bb4-719e-ac6a79dcc213 | 2025-10-30 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | Cardinal Health 107, LLC | 97007188-43fe-416c-a87b-6ccc4d9ae2ec | 2025-10-29 | Adverse reactions | Sodium Chloride |
| PEMETREXED | PEMETREXED | Hospira, Inc. | 3ae68628-7ab0-4491-b3ae-6a8330b719c8 | 2025-10-08 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium chloride | SODIUM CHLORIDE | Becton Dickinson and Company | ca3355f2-2cf0-4f58-bed5-0c4c0a7d3511 | 2025-10-08 | Warnings, Adverse reactions | Sodium chloride |
| Potassium Phosphates | POTASSIUM PHOSPHATES | Hospira, Inc. | 2fcbc814-c7a4-469a-8b1d-6819b961bfb9 | 2025-09-30 | Warnings, Adverse reactions | Hospira, Inc. |
| MILRINONE LACTATE | MILRINONE LACTATE | Hospira, Inc. | 813e8ca2-de54-4a7c-a2d2-8bd44396c341 | 2025-09-26 | Warnings, Adverse reactions | Hospira, Inc. |
| Methotrexate | METHOTREXATE | Hospira, Inc. | 0e30eaef-5a09-4104-8a11-c32933eadeab | 2025-08-22 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.